CIK 0001873835
- Emerging growth company
Immix Biopharma, Inc.
Sign in to watch- Ticker
- IMMX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 454869378
- Phone
- +1 888-958-1084
- Business address
- 11400 WEST OLYMPIC BLVD., SUITE 200, LOS ANGELES, CA, 90064
- Former names
- Immix Biopharma, Inc.
- Open-market buys, last 90 days
- $20,011
- in 2 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$20,011. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-18 | Rachman Ilya M CEO, Chairman | Purchase | +1,408.45 | $7.10 | $10K | 1,143,091.45 |
| 2026-11-18 | Morris Gabriel S CFO, President | Purchase | +1,418 | $7.06 | $10K | 292,847 |
| 2026-05-22 | Ng Carey Director | Grant or award | +6,250 | 26,250 | ||
| 2026-05-22 | Ng Carey Director | Grant or award · Stock Option (Right to Buy) | +12,500 | 12,500 | ||
| 2026-05-22 | Adams Helen C. Director | Grant or award | +6,250 | 181,004 | ||
| 2026-05-22 | Adams Helen C. Director | Grant or award · Stock Option (Right to Buy) | +12,500 | 12,500 | ||
| 2026-05-22 | Morris Gabriel S CFO, President | Grant or award · Stock Option (Right to Buy) | +500,000 | 500,000 | ||
| 2026-05-22 | Marquet Magda Director | Grant or award | +6,250 | 52,342 | ||
| 2026-05-22 | Marquet Magda Director | Grant or award · Stock Option (Right to Buy) | +12,500 | 12,500 | ||
| 2026-05-22 | CHANG NANCY T Director | Grant or award | +6,250 | 428,190 | ||
| 2026-05-22 | CHANG NANCY T Director | Grant or award · Stock Option (Right to Buy) | +12,500 | 12,500 | ||
| 2026-05-22 | Rachman Ilya M CEO and Chairman | Grant or award · Stock Option (Right to Buy) | +500,000 | 500,000 | ||
| 2026-05-22 | Chudnovsky Yekaterina Director | Grant or award | +6,250 | 6,250 | ||
| 2026-05-22 | Chudnovsky Yekaterina Director | Grant or award · Stock Option (Right to Buy) | +12,500 | 12,500 | ||
| 2026-05-22 | BUCHAN JANE Director | Grant or award | +6,250 | 28,705 | ||
| 2026-05-22 | BUCHAN JANE Director | Grant or award · Stock Option (Right to Buy) | +12,500 | 12,500 | ||
| 2026-05-22 | Hsu Jason Director | Grant or award | +6,250 | 899,250 | ||
| 2026-05-22 | Hsu Jason Director | Grant or award · Stock Option (Right to Buy) | +12,500 | 12,500 | ||
| 2025-12-10 | Rachman Ilya M CEO and Chairman | Purchase | +746 | $6.67 | $5K | 1,141,683 |
| 2025-12-10 | Morris Gabriel S CFO | Purchase | +770 | $6.58 | $5K | 291,429 |
Page 1 of 7 · 126 trades